Neoadjuvant chemotherapy with standard vs high dose of epirubicin plus filgrastim for locally advanced breast cancer. Report from the mexican oncology study group (MOSG)

✍ Scribed by G. Morgan; C. Chan; J. Pott; L. Martignon; L. Perez-Michel; M. Ramírez; R. Zamora; J. Peralta; F. Delgadillo; L. Torrecillas

• Book ID: 117658486
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 357 KB
• Volume: 37
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(01)81121-7